about
Peripheral Nerve Ultrasonography in Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy: Correlations with Clinical and Neurophysiological Data.Orthostatic hypotension in Parkinson's disease: Does it matter if asymptomatic?Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.CIDP-like neuropathies in graft versus host disease.Integration of technology-based outcome measures in clinical trials of Parkinson and other neurodegenerative diseases.Thalamic deep brain stimulation for orthostatic tremor: A multicenter international registry.Essential pitfalls in "essential" tremor.Technology in Parkinson's disease: Challenges and opportunities.Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials.Advanced therapies in Parkinson's disease: Long-term retrospective study.Short-term efficacy of ultramicronized palmitoylethanolamide in peripheral neuropathic pain.Earlier versus later subthalamic deep brain stimulation in Parkinson's disease.The Parkinson Care Advocate: Integrating Care Delivery.Electrophysiological Predictors of Clinical Outcome in Traumatic Neuropathies: A Multicenter Prospective Study.Adaptive deep brain stimulation controls levodopa-induced side effects in Parkinsonian patients.Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients.Subthalamic nucleus deep brain stimulation outcome in young onset Parkinson's disease: a role for age at disease onset?Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson disease.Prospective assessment of peripheral neuropathy in Duodopa-treated parkinsonian patients.Subthalamic deep brain stimulation and trunk posture in Parkinson's disease.A polysomnographic study in parkinsonian patients treated with intestinal levodopa infusion.Deconstructing normal pressure hydrocephalus: Ventriculomegaly as early sign of neurodegeneration.Parkinsonism-hyperpyrexia syndrome and deep brain stimulation.Prevalence and burden of dysautonomia in advanced Parkinson's disease.Subthalamic or red nucleus? A puzzling question arising during intraoperative recording for DBS.Thalamic deep brain stimulation and gait in orthostatic tremor.Peripheral neuropathy as marker of severe Parkinson's disease phenotype.Autonomic dysfunction in Parkinson's disease: A prospective cohort study.Long-term duodenal levodopa infusion in Parkinson's disease: a 3-year motor and cognitive follow-up study.Does intraoperative microrecording really increase the risk of hemorrhagic complications in deep brain stimulation?Transdermal rotigotine in dihydropteridine reductase deficiency.Subthalamic deep brain stimulation: clinical and neuropsychological outcomes in mild cognitive impaired parkinsonian patients.Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease.Transient effects of 80 Hz stimulation on gait in STN DBS treated PD patients: a 15 months follow-up study.Orthostatic hypotension in Parkinson disease: Impact on health care utilization.Deep brain stimulation in cerebral palsy: Time for dynamism in a static encephalopathy.Future of Neurologic Examination in Clinical Practice.Effects of intestinal Levodopa infusion on freezing of gait in Parkinson disease.Subcutaneous "bolus" immunoglobulin dose in CIDP: A proof-of concept study.Peripheral neuropathy associated with levodopa-carbidopa intestinal infusion: a long-term prospective assessment.
P50
Q31108710-44B2B648-BCA9-4F15-9184-A2027619F5BEQ33167706-D1DD5FD9-C0C0-4A1E-A523-152A5BA5DB9FQ34986741-C87B7AB7-377F-4E07-839C-9B03E3BCDAD7Q38416605-B2C6194E-6842-46D5-844A-FEBAE5A75D3DQ38649148-D8C04510-AC29-4647-BBF5-A51DA9DBA7BDQ38717715-689AE58B-8A6E-4C16-B916-DE1CC29A9F85Q38766537-8C189221-1060-4E35-BD7E-C54D9FCE8747Q38820246-AA8C49E3-0D54-4F39-A36B-A01EEF493FB0Q39149219-600F3D84-F2C9-4112-A670-4866EBDBBC19Q39743119-93DF527F-6B4D-4D52-B91D-DD58F428646FQ40626367-DB809D7C-2405-48E7-8EB0-16C93081BC1CQ40851704-8F79F0B6-CB83-49AF-A83E-74CA37AC480DQ41140211-0345D411-F794-483A-B6A7-BCD52B7F4981Q41916715-9690DF54-E73E-4B0B-BED1-62FF78D88415Q42356319-C10723A1-72A0-48FA-8D8E-FA76A30CC937Q43544818-08D47973-6ECF-4CA6-9F77-2B2435D9785CQ45156822-8247A2D9-773F-4399-975A-20CC529A9F94Q45238296-6FDF6A17-37CD-4E91-83C5-B69FF6AF9502Q46160638-91BDC8DE-F760-4C8F-A374-0C7AE416DAD7Q47235937-0E8DE2AE-DBD2-4354-8BBE-D8DDB41D00AAQ47740158-AE0B7A8F-9E8C-4DFE-899F-A0787C282F35Q48092818-75B186F4-B5F3-476E-8135-AF35C3D7415EQ48109966-DD3751AE-0BF4-4626-B841-ED563886758BQ48283066-7B13FFC2-4332-4C8E-89E5-5E82A2F6B094Q48295680-FE840116-24EB-4373-A6FD-BF1983087A96Q48300819-B6246EBF-4C45-4E21-9D6D-6F8B55D2308EQ48326754-FE68FBF7-7D28-4EBF-B10A-333C2196E635Q48348979-D6596226-8642-481D-9FF3-2483FEAD6D58Q48419574-4521CB85-414A-4C9A-BF8D-2A69E09792A3Q48588079-D8C3A6FC-0207-4BD3-8149-29EA4E16F4B0Q48620332-056D8212-183E-4FD9-93A3-3F6E538A1A05Q48704189-A4422700-AF11-4337-88A7-312E1B0539CFQ48829557-6826388B-08F6-4370-A5FD-1A55A31348CFQ48958714-5A91952D-78C8-45E5-8962-544307959B5DQ49361442-DA85C8B1-5169-4E08-99FB-A624D52D84E4Q49972215-CF093C59-1F51-428B-94A9-777136756735Q50051814-50BB7671-3DE2-414E-9A71-55381C93635EQ50180846-2D59F3AD-7A83-4FF9-AEBF-885A1B566D1FQ50223747-65DE8592-2BFC-493D-8B4E-1EA73DC2E325Q53661046-83BEA2AB-E65F-4DBF-9C87-BD2573FEDF5C
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Aristide Merola
@ast
Aristide Merola
@en
Aristide Merola
@es
Aristide Merola
@nl
Aristide Merola
@sl
type
label
Aristide Merola
@ast
Aristide Merola
@en
Aristide Merola
@es
Aristide Merola
@nl
Aristide Merola
@sl
prefLabel
Aristide Merola
@ast
Aristide Merola
@en
Aristide Merola
@es
Aristide Merola
@nl
Aristide Merola
@sl
P106
P1153
20435871500
P21
P31
P496
0000-0002-5587-726X
P569
2000-01-01T00:00:00Z